Dietmar Hopp (Malte Ossowski/SVEN SIMON/picture-alliance/dpa/AP Images)
July 24, 2020 02:15 PM EDT
Financing

Bil­lion­aire Di­et­mar Hopp steers his se­cre­tive Covid-19 biotech play­er to Nas­daq fol­low­ing ma­jor pact with GSK

John Carroll

Editor & Founder

One of the most se­cre­tive biotech can­di­dates to lead the de­vel­op­ment of a new mR­NA vac­cine to fight Covid-19 just filed their IPO pa­pers for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times